Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
Feb 09, 2024•1 hr 3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
For the best experience, listen in Metacast app for iOS or Android